Doses
California hospitals overrun even as vaccine is rolled out
Even as high profile figures like U.S. Vice President Mike Pence rolled up their sleeves for COVID-19 vaccinations, patients already ill with the disease crowded emergency rooms and overran intensive care units in California, now a worldwide epicenter. Another 41,000 people tested positive in the most populous U.S. state on Thursday, and 300 died, state public health officials said. In a state with 40 million residents, only about 1,200 intensive care beds remained available by Friday – just 2.1% of the total, the California Department of Public Health said. “We anticipated a surge, but I’m not sure if anyone imagined it would be as bad as it has been,” said Adam Blackstone, a spokesman for the Hospital Association of Southern California. Hospitals are strained under the press of patients,...
First Americans vaccinated as U.S. death toll passes 300,000
An intensive care unit nurse became the first person in the United States to receive the Pfizer/BioNTech COVID-19 vaccine on Monday, calling it a sign that “healing is coming,” as the U.S. coronavirus death toll crossed a staggering 300,000 lives lost. Sandra Lindsay, who has treated some of the sickest COVID-19 patients for months, was given the vaccine at Long Island Jewish Medical Center in the New York City borough of Queens, an early epicenter of the country’s COVID-19 outbreak, receiving applause on a livestream with New York Governor Andrew Cuomo. “It didn’t feel any different from taking any other vaccine,” Lindsay said. “I feel hopeful today, relieved. I feel like healing is coming. I hope this marks the beginning of the end of a very painful time in our history. “I want to instil...
Canada approves Pfizer-BioNTech coronavirus vaccine
Canadian health officials have authorised the Pfizer-BioNTech COVID-19 vaccine, hailing the development as a “critical milestone” and paving the way for the inoculant to be administered across the country. The authorisation on Wednesday comes a day after the United Kingdom became the first country to begin giving the vaccine to the public. Emergency use authorisation (EUA) is also pending in the United States, with officials saying the first doses could be administered as early as next week. The US Food and Drug Administration is scheduled to consider its EUA on Thursday. Bahrain has also authorised the vaccine for public use. “Canadians can feel confident that the review process was rigorous and that we have strong monitoring systems in place,” Health Canada, the department responsible fo...
France: Coronavirus vaccine will be free for all
France will ensure free COVID-19 vaccinations for all who are in its social security system and has earmarked 1.5 billion euros of next year’s social security budget to cover the cost, Prime Minister Jean Castex said on Thursday. Castex said the vaccination campaign would begin in a matter of weeks, pending regulatory approval by the European Medicines Agency. The inoculation programme would be staggered over three categories of people, he said, commencing with the most vulnerable in nursing homes. “The vaccination will be free for all,” Castex told a press conference. France has ordered some 200 million doses from different pharmaceutical companies developing vaccines, Castex said, enough to inoculate 100 million people – more than France’s population. The COVID-19 vaccination will be vol...
Coronavirus vaccine breakthrough raises hopes of rapid global rollout
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
Spain touts mass vaccine plan, sees light at tunnel’s end
After months of turmoil and over 42,000 deaths, Spain appeared to see light at the end of the tunnel Friday, announcing ambitious plans to vaccinate much of the population by mid-2021. The post Spain touts mass vaccine plan, sees light at tunnel’s end appeared first on TODAY. You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process. Earn rewards by chatting, sharing photos, blogging and help give users back their fair share of Internet revenue.
WHO: World records 207,500 measles deaths in 2019, amid increases in cases to 869,770
Global measles deaths increased by 50 per cent from 2016 to 2019, claiming over 207,500 lives in 2019, WHO said in a statement issued from its headquarters on Thursday in Geneva citing figures from a joint report it published with the US Centre for Disease Control (CDC). The post WHO: World records 207,500 measles deaths in 2019, amid increases in cases to 869,770 appeared first on TODAY. You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process. Earn rewards by chatting, sharing photos, blogging and help give users back their fair share of Internet revenue.
Europe to pay less than US for Pfizer COVID-19 vaccine
The European Union has struck a deal to initially pay less for Pfizer’s COVID-19 vaccine candidate than the United States, an EU official told Reuters News Agency as the bloc announced on Wednesday it had secured an agreement for up to 300 million doses. The experimental drug, developed in conjunction with Germany’s BioNTech, is the frontrunner in a global race to produce a vaccine, with interim data released on Monday showing it was more than 90 percent effective at protecting people from COVID-19 in a large-scale clinical trial. Under the EU deal, 27 European countries could buy 200 million doses, and have an option to buy another 100 million. The bloc will pay less than $19.50 per jab, a senior EU official involved in talks with vaccine makers told Reuters, adding that partly reflected ...
